CELU Celularity Inc
Nasdaq · SEC CIK 1752828 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 150 since 2021-07-16, latest 2026-06-23 10:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LeVien Vincent | Dir | — | — |
| Brigido Stephen | Pres, Functional Regeneration | — | — |
| Haines John R | Senior Exec VP | — | — |
| Ling Geoffrey M.D. | Dir | — | — |
| Parks Diane L. | Dir | — | — |
| Diamandis Peter | Dir | — | — |
| Hariri Robert J | CEO, Dir | — | — |
Transactions 125
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | M - OptEx | $0.00 | +821 | 9,742 | +9% | $0 |
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $1.28 | -268 | 9,474 | -3% | -$343.04 |
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Haines John R | Senior Exec VP | M - OptEx | $0.00 | +1,641 | 30.8K | +6% | $0 |
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Haines John R | Senior Exec VP | F - Tax | $1.28 | -583 | 30.2K | -2% | -$746.24 |
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $0.00 | +3,281 | 2.85M | +0.1% | $0 |
| D | 2026-04-15 16:30 | 2026-04-13 | CELU | Hariri Robert J | CEO, Dir | F - Tax | $1.28 | -1,182 | 2.85M | -0.0% | -$1,513 |
| A | 2026-01-15 | 2026-01-12 | CELU | LeVien Vincent | Dir | A - Grant | $0.00 | +28.8K | 153.8K | +23% | $0 |
| A | 2026-01-15 | 2026-01-12 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +19.2K | 256.0K | +8% | $0 |
| A | 2026-01-15 | 2026-01-12 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +30.0K | 520.0K | +6% | $0 |
| A | 2026-01-15 | 2026-01-12 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +20.4K | 394.1K | +5% | $0 |
| 2026-01-14 | 2026-01-12 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +30.0K | 520.0K | +6% | $0 | |
| 2026-01-14 | 2026-01-12 | CELU | LeVien Vincent | Dir | A - Grant | $0.00 | +28.8K | 153.8K | +23% | $0 | |
| 2026-01-14 | 2026-01-12 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +20.4K | 394.1K | +5% | $0 | |
| 2026-01-14 | 2026-01-12 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +19.2K | 256.0K | +8% | $0 | |
| D | 2025-12-30 | 2025-12-29 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +125.0K | 236.8K | +112% | $0 |
| D | 2025-12-30 | 2025-12-29 | CELU | LeVien Vincent | Dir | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
| D | 2025-12-30 | 2025-12-29 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +125.0K | 490.0K | +34% | $0 |
| D | 2025-12-30 | 2025-12-29 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +125.0K | 373.8K | +50% | $0 |
| 2025-12-22 | 2025-12-19 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +67.4K | 111.8K | +152% | $0 | |
| 2025-12-22 | 2025-12-19 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +67.4K | 365.0K | +23% | $0 | |
| 2025-12-22 | 2025-12-19 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +67.4K | 248.8K | +37% | $0 | |
| 2025-11-21 | 2025-11-19 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +61.5K | 365.0K | +20% | $0 | |
| 2025-11-21 | 2025-11-19 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +47.0K | 248.8K | +23% | $0 | |
| 2025-11-21 | 2025-11-19 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +44.4K | 111.8K | +66% | $0 | |
| 2025-11-21 | 2025-11-19 | CELU | LeVien Vincent | Dir | A - Grant | $0.00 | +3,699 | 3,699 | New | $0 | |
| DA | 2025-06-04 | 2025-04-13 | CELU | Hariri Robert J | CEO, Dir | F - Tax | $1.64 | -1,154 | 2.85M | -0.0% | -$1,893 |
| DA | 2025-06-04 | 2025-04-13 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $0.00 | +3,281 | 2.85M | +0.1% | $0 |
| D | 2025-04-15 | 2025-04-13 | CELU | Hariri Robert J | CEO, Dir | F - Tax | $1.64 | -1,154 | 20.3K | -5% | -$1,893 |
| D | 2025-04-15 | 2025-04-13 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $0.00 | +3,281 | 21.5K | +18% | $0 |
| D | 2025-04-15 | 2025-04-13 | CELU | Haines John R | Senior Exec VP | F - Tax | $1.64 | -577 | 29.1K | -2% | -$946.28 |
| D | 2025-04-15 | 2025-04-13 | CELU | Haines John R | Senior Exec VP | M - OptEx | $0.00 | +1,641 | 29.7K | +6% | $0 |
| D | 2025-04-15 | 2025-04-13 | CELU | Beers David C | CFO | M - OptEx | $0.00 | +1,025 | 18.6K | +6% | $0 |
| D | 2025-04-15 | 2025-04-13 | CELU | Beers David C | CFO | F - Tax | $1.64 | -360 | 18.2K | -2% | -$590.40 |
| D | 2025-04-15 | 2025-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $1.64 | -268 | 8,921 | -3% | -$439.52 |
| D | 2025-04-15 | 2025-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | M - OptEx | $0.00 | +820 | 9,189 | +10% | $0 |
| DA | 2025-03-03 | 2024-12-19 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +67.4K | 201.7K | +50% | $0 |
| D | 2025-02-19 | 2025-02-17 | CELU | Beers David C | CFO | F - Tax | $2.14 | -4,396 | 17.5K | -20% | -$9,407 |
| D | 2025-02-19 | 2025-02-17 | CELU | Beers David C | CFO | M - OptEx | $0.00 | +12.5K | 21.9K | +133% | $0 |
| D | 2025-02-19 | 2025-02-17 | CELU | Haines John R | Senior Exec VP | F - Tax | $2.14 | -7,035 | 28.1K | -20% | -$15.1K |
| D | 2025-02-19 | 2025-02-17 | CELU | Haines John R | Senior Exec VP | M - OptEx | $0.00 | +20.0K | 35.1K | +133% | $0 |
| D | 2025-02-19 | 2025-02-17 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $2.14 | -3,272 | 8,369 | -28% | -$7,002 |
| D | 2025-02-19 | 2025-02-17 | CELU | Brigido Stephen | Pres, Functional Regeneration | M - OptEx | $0.00 | +10.0K | 11.6K | +609% | $0 |
| DMI | 2025-01-28 | 2025-01-24 | CELU | Genting Berhad | 10% | X - OptEx | $2.07 | +1.19M | 6.34M | +23% | +$2.46M |
| D | 2025-01-07 | 2024-12-19 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +67.4K | 303.5K | +29% | $0 |
| D | 2025-01-06 | 2024-12-19 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +67.4K | 1.37M | +5% | $0 |
| D | 2025-01-06 | 2024-12-19 | CELU | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +67.4K | 67.4K | New | $0 |
| D | 2025-01-06 | 2024-12-19 | CELU | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +67.4K | 67.4K | New | $0 |
| D | 2025-01-06 | 2024-12-19 | CELU | Kehler Dean C | Dir | A - Grant | $0.00 | +67.4K | 303.5K | +29% | $0 |
| 2024-04-16 | 2024-04-13 | CELU | Haines John R | See Remarks | F - Tax | $4.11 | -576 | 38.4K | -1% | -$2,367 | |
| 2024-04-16 | 2024-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $4.11 | -268 | 19.5K | -1% | -$1,101 | |
| 2024-04-16 | 2024-04-13 | CELU | Beers David C | CFO | F - Tax | $4.11 | -360 | 24.0K | -1% | -$1,480 | |
| 2024-04-16 | 2024-04-13 | CELU | Hariri Robert J | CEO | F - Tax | $4.11 | -1,154 | 2.86M | -0.0% | -$4,743 | |
| 2024-04-16 | 2024-04-13 | CELU | Fletcher Kyle | See Remarks | F - Tax | $4.11 | -20 | 21.1K | -0.1% | -$82.20 | |
| 2024-03-19 | 2024-03-15 | CELU | Fletcher Kyle | See Remarks | F - Tax | $5.68 | -617 | 21.1K | -3% | -$3,505 | |
| D | 2024-02-21 | 2024-02-17 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $0.43 | -32.7K | 197.4K | -14% | -$14.1K |
| D | 2024-02-21 | 2024-02-17 | CELU | Kilcoyne Adrian | Chief Medical Off | F - Tax | $0.43 | -52.8K | 1.12M | -4% | -$22.7K |
| D | 2024-02-21 | 2024-02-17 | CELU | Haines John R | See Remarks | F - Tax | $0.43 | -70.3K | 389.5K | -15% | -$30.3K |
| D | 2024-02-21 | 2024-02-17 | CELU | Beers David C | CFO | F - Tax | $0.43 | -44.0K | 243.4K | -15% | -$18.9K |
| D | 2024-02-21 | 2024-02-17 | CELU | Fletcher Kyle | See Remarks | F - Tax | $0.43 | -39.6K | 217.2K | -15% | -$17.0K |
| DI | 2024-01-17 | 2024-01-12 | CELU | Genting Berhad | 10% | P - Purchase | $0.25 | +21.41M | 51.47M | +71% | +$5.35M |
| M | 2023-10-10 | 2023-09-29+ | CELU | Hariri Robert J | CEO, Dir | P - Purchase | $0.1649 | +18.42M | 25.52M | +260% | +$3.04M |
| M | 2023-10-05 | 2023-09-29+ | CELU | Sorrento Therapeutics, Inc. | 10% | S - Sale | — | -15.37M | 11.36M | -58% | — |
| 2023-07-19 | 2023-07-14 | CELU | Kilcoyne Adrian | Chief Medical Off | A - Grant | $0.00 | +875.0K | 1.18M | +292% | $0 | |
| A | 2023-06-30 | 2023-06-14 | CELU | Lim Kok Thay | Dir | F - Tax | $0.75 | -10.8K | 225.2K | -5% | -$8,133 |
| D | 2023-06-16 | 2023-06-14 | CELU | Lim Kok Thay | Dir | A - Grant | $0.00 | +199.9K | 236.1K | +553% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | Smith Robin L | Dir | A - Grant | $0.00 | +199.9K | 236.1K | +553% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | Parks Diane L. | Dir | A - Grant | $0.00 | +199.9K | 236.1K | +553% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | Kehler Dean C | Dir | A - Grant | $0.00 | +199.9K | 236.1K | +553% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | VON ESCHENBACH ANDREW C. | Dir | A - Grant | $0.00 | +199.9K | 336.1K | +147% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | Mazur Marc | Dir | A - Grant | $0.00 | +199.9K | 236.1K | +553% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | SCULLEY JOHN | Dir | A - Grant | $0.00 | +199.9K | 1.00M | +25% | $0 |
| D | 2023-06-16 | 2023-06-14 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +199.9K | 1.31M | +18% | $0 |
| 2023-04-17 | 2023-04-13 | CELU | Glover Bradley | See Remarks | F - Tax | $0.71 | -2,884 | 351.2K | -0.8% | -$2,048 | |
| 2023-04-17 | 2023-04-13 | CELU | Hariri Robert J | CEO, Dir | F - Tax | $0.71 | -11.5K | 10.15M | -0.1% | -$8,193 | |
| 2023-04-17 | 2023-04-13 | CELU | Fletcher Kyle | See Remarks | F - Tax | $0.71 | -201 | 256.8K | -0.1% | -$142.71 | |
| 2023-04-17 | 2023-04-13 | CELU | Beers David C | CFO | F - Tax | $0.71 | -3,606 | 287.4K | -1% | -$2,560 | |
| 2023-04-17 | 2023-04-13 | CELU | Brigido Stephen | Pres, Functional Regeneration | F - Tax | $0.71 | -2,683 | 230.1K | -1% | -$1,905 | |
| 2023-04-17 | 2023-04-13 | CELU | Haines John R | See Remarks | F - Tax | $0.71 | -5,770 | 459.8K | -1% | -$4,097 | |
| 2023-03-30 | 2023-03-15 | CELU | Fletcher Kyle | See Remarks | F - Tax | $0.63 | -2,170 | 257.0K | -0.8% | -$1,367 | |
| D | 2023-03-27 | 2023-03-27 | CELU | Hariri Robert J | CEO, Dir | A - Grant | $0.83 | +2.08M | 10.16M | +26% | +$1.73M |
| 2023-02-22 | 2023-02-17 | CELU | Haines John R | Senior Exec VP | A - Grant | — | +400.0K | 465.6K | +610% | — | |
| 2023-02-22 | 2023-02-17 | CELU | Brigido Stephen | Pres, Functional Regeneration | A - Grant | — | +200.0K | 232.8K | +610% | — | |
| 2023-02-22 | 2023-02-17 | CELU | Fletcher Kyle | See Remarks | A - Grant | — | +225.0K | 259.2K | +658% | — | |
| 2023-02-22 | 2023-02-17 | CELU | Beers David C | CFO | A - Grant | — | +250.0K | 291.0K | +610% | — | |
| 2023-02-22 | 2023-02-17 | CELU | Kilcoyne Adrian | Chief Medical Off | A - Grant | — | +300.0K | 300.0K | New | — | |
| 2023-02-22 | 2023-02-17 | CELU | Glover Bradley | See Remarks | A - Grant | — | +300.0K | 354.1K | +555% | — | |
| D | 2023-02-14 | 2023-02-10 | CELU | Diamandis Peter | Dir | M - OptEx | $0.28 | +1.07M | 1.11M | +2,963% | +$299.9K |
| 2022-11-30 | 2022-11-30 | CELU | Hariri Robert J | CEO, Dir | P - Purchase | $1.72 | +10.0K | 8.07M | +0.1% | +$17.2K | |
| 2022-11-29 | 2022-11-29 | CELU | Hariri Robert J | CEO, Dir | P - Purchase | $1.71 | +40.0K | 8.06M | +0.5% | +$68.4K | |
| 2022-11-28 | 2022-11-28 | CELU | Hariri Robert J | CEO, Dir | P - Purchase | $1.74 | +40.0K | 8.02M | +0.5% | +$69.6K | |
| 2022-11-18 | 2022-11-16 | CELU | Fletcher Kyle | GC | F - Tax | $1.89 | -1,262 | 34.2K | -4% | -$2,385 | |
| 2022-11-18 | 2021-11-16 | CELU | Jones Anne | Chief Business Off | A - Grant | $0.00 | +25.0K | 52.9K | +90% | $0 | |
| 2022-11-18 | 2022-11-16 | CELU | Jones Anne | Chief Business Off | F - Tax | $1.89 | -3,734 | 49.2K | -7% | -$7,057 | |
| 2022-11-18 | 2021-11-16 | CELU | Glover Bradley | See Remarks | F - Tax | $1.89 | -3,734 | 54.1K | -6% | -$7,057 | |
| 2022-11-18 | 2021-11-16 | CELU | Glover Bradley | See Remarks | A - Grant | $0.00 | +25.0K | 57.8K | +76% | $0 | |
| D | 2022-08-30 | 2022-08-26 | CELU | SCULLEY JOHN | Dir | M - OptEx | $0.28 | +768.6K | 804.7K | +2,126% | +$215.2K |
| D | 2022-08-25 | 2022-08-24 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $2.87 | +119.1K | 7.98M | +2% | +$341.7K |
| D | 2022-07-15 | 2022-07-13 | CELU | Diamandis Peter | Dir | A - Grant | $0.00 | +36.1K | 36.1K | New | $0 |
| D | 2022-07-15 | 2022-07-13 | CELU | Fletcher Kyle | GC | A - Grant | $0.00 | +2,297 | 35.4K | +7% | $0 |
| D | 2022-07-15 | 2022-07-13 | CELU | VON ESCHENBACH ANDREW C. | Dir | A - Grant | $0.00 | +36.1K | 136.1K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations